Background Molecular subtype of breast cancer is associated with sentinel lymph node
status. We sought to establish a mathematical prediction model that included breast cancer …

Background Previous studies suggested that the molecular subtypes were strongly
associated with sentinel lymph node (SLN) status. The purpose of this study was to …

Introduction To decipher the interaction between the molecular subtype classification and
the probability of a non-sentinel node metastasis in breast cancer patients with a metastatic …

Background: Nomogram accuracies for predicting non-sentinel lymph node (SLN)
involvement vary between different patient populations. Our aim is to put these nomograms …

Several models for predicting the risk of non‐sentinel lymph node (NSLN) metastasis in
breast cancer patients with positive sentinel lymph nodes (SLNs) have been developed. The …

Aim: The standard-of-care in breast cancer (BC) with positive sentinel lymph node (SLN)
metastasis includes complete axillary lymph node dissection (ALND); however, almost half …

We aimed to analyze the risk factors and construct a new nomogram to predict non-sentinel
lymph node (NSLN) metastasis for cT1-2 breast cancer patients with positivity after sentinel …

Completion axillary lymph node dissection (cALND) is the golden standard if breast cancer
involves the sentinel lymph node (SLN). However, most non-sentinel lymph nodes (NSLN) …

Objectives: Over the years, completion axillary lymph node dissection is recommended for
the patients with breast cancer if sentinel lymph node metastasis is found. However, not all …

To present a systemic review and meta-analysis to evaluate the nomograms developed to
predict non-sentinel lymph node (NSLN) metastasis in breast cancer patients. We focused …